Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs SOLS✓SelectedUSD · SOLSGSK vs SOLS performance historyLatest closeAs of-0.13%11/20
Stock and ETF performance explorer

GSK vs SOLS

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+13.1%
SOLS return
+15.2%
Excess return
-2.1%
Maximum drawdown
-22.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioSOLSExcessAlpha
1D-0.1%-6.2%+6.1%-0.3%
7D-5.3%-8.4%+3.1%-5.5%
30D-3.7%-6.8%+3.2%-3.8%
3M-7.3%+7.1%-14.3%-7.3%
6M-4.2%-28.2%+23.9%-4.0%
YTD+0.9%+25.0%-24.2%+3.2%
1Y+7.3%+40.4%-33.2%+10.2%
All+13.1%+15.2%-2.1%+16.0%

Cumulative growth

Daily Returns

Daily percentage return beside SOLS.

Daily Out/Under-Performance

Portfolio return minus SOLS return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × SOLS return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded SOLS wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling